SMS Lifesciences India Limited has informed the Exchange about Copy of Newspaper Publication
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Lifesciences India Limited has filed copies of newspaper advertisements (Business Standard in English and Telugu Prabha in Telugu) publishing its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025), as required under SEBI LODR Regulation 47(1)(b) within 48 hours of its August 11, 2025 board meeting. On a standalone basis, total income from operations fell to Rs 7,904.27 lakhs from Rs 8,657.06 lakhs year-on-year, while net profit after tax dropped to Rs 515.77 lakhs from Rs 645.99 lakhs. On a consolidated basis, total income declined to Rs 8,250.46 lakhs (from Rs 9,254.82 lakhs) and net profit after tax fell sharply to Rs 438.21 lakhs (from Rs 709.63 lakhs), translating to a lower EPS of Rs 13.75 versus Rs 22.99 in the year-ago quarter. The underlying numbers point to a weak quarter, though the filing itself is a routine regulatory compliance disclosure.
The results show a clear year-on-year weakness, with consolidated profit after tax down around 38% and revenue down about 11%, which could weigh on short-term investor sentiment. The filing itself is a standard SEBI-mandated newspaper publication of already-disclosed results, with no new corporate action.